Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Compare Balance Sheet Results of Vista Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.31
15.83
-3.52
-22.24%
Share Warrants & Outstandings
Total Reserve
33.10
132.83
-99.73
-75.08%
Shareholder's Funds
45.42
148.66
-103.24
-69.45%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.38
9.23
-6.85
-74.21%
Secured Loans
2.38
8.70
-6.32
-72.64%
Unsecured Loans
0.00
0.53
-0.53
-100.00%
Deferred Tax Assets / Liabilities
-4.37
9.82
-14.19
-144.50%
Other Long Term Liabilities
0.00
6.80
-6.80
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.12
0.00
0.12
0.00%
Total Non-Current Liabilities
-1.87
25.84
-27.71
-107.24%
Current Liabilities
Trade Payables
5.59
91.32
-85.73
-93.88%
Other Current Liabilities
1.74
20.38
-18.64
-91.46%
Short Term Borrowings
5.02
71.94
-66.92
-93.02%
Short Term Provisions
0.01
1.10
-1.09
-99.09%
Total Current Liabilities
12.37
184.74
-172.37
-93.30%
Total Liabilities
55.92
359.24
-303.32
-84.43%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.18
261.84
-234.66
-89.62%
Less: Accumulated Depreciation
8.48
121.18
-112.70
-93.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18.70
140.66
-121.96
-86.71%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
10.14
0.00
10.14
0.00%
Intangible assets under development
0.00
2.69
-2.69
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.03
0.02
66.67%
Long Term Loans & Advances
2.12
2.01
0.11
5.47%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
31.01
160.25
-129.24
-80.65%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.22
138.80
-130.58
-94.08%
Sundry Debtors
13.54
39.07
-25.53
-65.34%
Cash and Bank
0.73
2.57
-1.84
-71.60%
Other Current Assets
0.41
1.64
-1.23
-75.00%
Short Term Loans and Advances
2.00
16.90
-14.90
-88.17%
Total Current Assets
24.91
198.99
-174.08
-87.48%
Net Current Assets (Including Current Investments)
12.54
14.25
-1.71
-12.00%
Total Current Assets Excluding Current Investments
24.91
198.99
-174.08
-87.48%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
55.92
359.24
-303.32
-84.43%
Contingent Liabilities
0.00
34.64
-34.64
-100.00%
Total Debt
7.40
81.33
-73.93
-90.90%
Book Value per share (adjusted)
7.38
93.92
-86.54
-92.14%
Annual - Borrowings
Borrowings 7.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 28.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 24.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024






